<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>As a result of complex studies, out of 275 patients with <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, cardiospinal syndromes were distinguished in 68 cases (24,6%) </plain></SENT>
<SENT sid="1" pm="."><plain>Of these, 14 manifested a syndrome of the anterior spinal artery, 6 a syndrome of the posterior longitudinal arteries </plain></SENT>
<SENT sid="2" pm="."><plain>Disturbances of spinal circulation in the system of the radicular spinal arteries were revealed in 48 patients </plain></SENT>
<SENT sid="3" pm="."><plain>Clinically, they involved a cardiohumerospinal syndrome (18 patients), cardio-intercostal spinal syndrome (9 patients), and cardio-<z:e sem="disease" ids="C0392548" disease_type="Disease or Syndrome" abbrv="">lumbosacral syndrome</z:e> (21 patients) </plain></SENT>
<SENT sid="4" pm="."><plain>Complex therapy of the cardiospinal syndromes (besides <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> treatment) included parenteral administration of 10% <z:chebi fb="199" ids="26708">sodium</z:chebi> <z:chebi fb="1" ids="30762">salicylate</z:chebi>, solkoseryl, troxevasin, dibazol, <z:chebi fb="0" ids="42944">galanthamine</z:chebi> (in the <z:e sem="disease" ids="C0857175" disease_type="Disease or Syndrome" abbrv="">postinfarction</z:e> period), proserin, as well as oral administration of antisclerotic, metabolic, nootropic and venotonic drugs </plain></SENT>
<SENT sid="5" pm="."><plain>Complete regression of the spinal symptoms was recorded in 35, improvement in 12 patients </plain></SENT>
<SENT sid="6" pm="."><plain>In the remaining patients, the recovery was negligible, and such patients were administered repeated courses of treatment </plain></SENT>
</text></document>